BioInformant.com is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by the Wall Street Journal, Xconomy, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.
The Global Exosome Market – Market Size, Forecast, Trials and Trends, 2021
By BioInformant Worldwide, L.L.C. | Biotechnology | May 2021 | Page 276
The Global Exosome Market – Market Size, Forecast, Trials and Trends, 2021 market research report available in single user pdf license with Aarkstore Enterprise at USD 3997....
Global Cord Blood Banking Industry Report 2021
By BioInformant Worldwide, L.L.C. | Healthcare | Feb 2021 | Page 232
Global Cord Blood Banking Industry Report 2021....
Mesenchymal Stem Cells - Advances and Applications, 2021
By BioInformant Worldwide, L.L.C. | Healthcare | Feb 2021 | Page 276
Mesenchymal Stem Cells - Advances and Applications, 2021 market research report available in single user pdf license with Aarkstore Enterprise at USD 5500....
Stem Cell Research Products - Opportunities, Tools, & Technologies
By BioInformant Worldwide, L.L.C. | Biotechnology | Oct 2020 | Page 175
Stem Cell Research Products - Opportunities, Tools, & Technologies....
Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends
By BioInformant Worldwide, L.L.C. | Healthcare | Feb 2019 | Page 195
CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer. ....
